Thomas Rose | Head of Expression Systems
ProBioGen AG

Thomas Rose, Head of Expression Systems, ProBioGen AG

Thomas Rose, PhD, is Head of Expression Systems at ProBioGen. He received his MSc in Biotechnology from the University of Applied Science in Berlin, his PhD in Biochemistry from the Free University of Berlin and joined ProBioGen in 2001. His work focuses on cell line development and expression technologies for protein drugs. He was instrumental in establishing the Freedom™ CHO-S™ Kit, as well as ProBioGen’s CHO.RiGHT® platform, Pathway Modulator and DirectedLuck® technologies. He also has extensive experience in cell line development for a variety of complex proteins.

Appearances:



Festival of Biologics Day 1 @ 17:30

Directed Luck®: Transposase targeting and Transposon design push expression beyond limits

Transposases have eased cell line development. Taking this concept to a new level, we equipped our hyperactive transposase with epigenetic readers that targets highly active genomic sites in the host cell line and designed advanced transposons with optimized ITRs for most efficient and clean integration. DirectedLuck® delivers highly productive clones and bulk pools ready for manufacturing and is particularly suited for heterodimeric formats, polyclonal antibody cell lines and viral vector packaging cell lines.

last published: 01/Aug/25 16:05 GMT

back to speakers

Get involved at Festival of Biologics Basel 2025

 

 

TO SPONSOR


Derek Cavanagh

[email protected]

 

Jack Bebb
[email protected]

 

TO SPEAK


Jack Beard
[email protected]

 

MARKETING & PRESS


Ollie McDaid

[email protected]

 

Stay Up-to-Date

Join our mailing list to receive exclusive content and offers.

By submitting, you agree to receive email communications from Terrapinn, including upcoming promotions and discounted tickets and news.